India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued a fresh warning regarding the safety of popular cosmetic procedures such as Botox, fillers, and IV drips. Many clinics advertise these treatments as simple cosmetic procedures, promising quick transformations that motivate consumers to undergo them without adequate research.
Risks of Unregulated Cosmetic Treatments
The CDSCO alert highlights that these procedures, while commonly marketed as safe, can pose serious health risks if not performed by qualified professionals or if unapproved products are used. The regulator emphasizes that consumers should verify the credentials of practitioners and ensure that products are approved by the CDSCO.
Common Side Effects and Complications
Botox injections can cause bruising, headache, or flu-like symptoms, while fillers may lead to allergic reactions, infections, or even tissue necrosis. IV drips, often marketed for detox or energy boosts, can cause infections, electrolyte imbalances, or allergic reactions if not administered properly.
Regulatory Measures
The CDSCO has urged state drug controllers to crack down on unauthorized clinics and unlicensed practitioners. It also advises consumers to report any adverse effects to the nearest health authority. The regulator is considering stricter guidelines for advertising such procedures to prevent misleading claims.
Consumers are advised to consult a certified dermatologist or plastic surgeon before undergoing any cosmetic treatment and to avoid bargain deals that may compromise safety. The CDSCO continues to monitor the situation and will take appropriate action to ensure public safety.
